Search Results
Results found for "Ross Cheloha"
- Dr. Ross Bathgate becomes Scientific co-founder of LASEREDD Therapeutics
I’m happy to share that I’m starting a new position as Scientific co-founder LASEREDD Therapeutics" Ross
- 📰 GPCR Weekly News, June 5 to 11, 2023
Ines Liebscher, Ross Cheloha and Silvio Gutkind.
- 📰 GPCR Weekly News, May 27 to June 2, 2024
Canonical chemokine receptors as scavenging “decoys” Shivani Sachdev, Brendan Creemer, Thomas Gardella, and Ross Cheloha for their work on Highly biased agonism for GPCR ligands via nanobody tethering Elk Kossatz,
- 📰 GPCR Weekly News, February 12 to 18, 2024
Nayara Braga Emidio, Ross Cheloha, Laura M Wingler, et al. for their work on Nanobody-Mediated Dualsteric
- 📰 GPCR Weekly News, December 11 to 17, 2023
Ross Cheloha's research involves semi-synthetic nanobody-ligand conjugates with enhanced transcriptional
- Dr. Rosie Dawaliby Podcast!
Rosie Dawaliby! Watch the full video with a Dr. GPCR Ecosystem paid membership ➡️ https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ep-84-with-rosie-dawaliby
- Dual loss of regulator of G protein signaling 2 and 5 exacerbates ventricular myocyte arrhythmias...
October 2022 Dual loss of regulator of G protein signaling 2 and 5 exacerbates ventricular myocyte arrhythmias
- N-terminal alterations turn the gut hormone GLP-2 into an antagonist with gradual loss of GLP-2 ...
October 2022 N-terminal alterations turn the gut hormone GLP-2 into an antagonist with gradual loss of
- Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes
Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes: Impact of of 11 Class A GPCR crystallized in multiple activation states (giving rise to 37 self-docking and 68 cross Our results show that one specific subset of cross-docking simulations gave results of similar quality RMSD values for top-scored poses were 1.2 Å and 2.0 Å for self-docking and StateMatch/FunctionMatch cross-docking
- 📰 GPCR Weekly News, July 1 to 7, 2024
Ross Bathgate, Francisco Olucha-Bordonau, et al.
- Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology
We collaborate and cross-pollenate a lot.” Mark: “Beth, why would someone want you as their boss?”
- Hear the sounds: the role of G protein-coupled receptors in the cochlea
for the understanding of the cochlea development, hearing disorders, and the treatment for hearing loss In addition, hearing loss can be caused by mutations of certain GPCRs, such as Vlgr1, Gpr156, S1P2, and A1, A2A, and CB2 activation by agonists has protective functions on noise- or drug-induced hearing loss GPCR in the cochlea and discuss the role of GPCR in the cochlea, such as stem cell fate, PCP, hearing loss
- Dr. GPCR Updates
It highlights its journey from one receptor to a cross-family toolkit. Hear from Drs.
- Lab Leadership Without Ego: How Sokhom Pin Built the Happiest Team at Alkermes
I was up every night thinking about how to hire, how to lead, how to avoid the mistakes my bad bosses
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
It’s about finding purpose through loss, choosing academia when many peers walk away, and designing science That personal loss transforms complex receptor pharmacology into something immediate and human.
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
The cross-talk between growth factor receptors and GPCRs is an intriguing area of study. consequences of specific phosphorylation events provide a deeper understanding of the molecular basis for cross-talk
- Signals in Motion: Pain, Metabolism & Terry’s Corner
Novo Nordisk’s amycretin showed up to 24% weight loss, CagriSema delivered 22.7% in Phase 3, and semaglutide
- Diversification of PAR signaling through receptor crosstalk
physiological and pathological relevance of these interactions, since this additional level of molecular cross-talk
- Crinetics Pharmaceuticals Announces Pricing Of Underwritten Common Stock Offering
The gross proceeds to Crinetics from the offering, before deducting the underwriting discounts and commissions
- Profiling Immune Cell and Platelet Transcriptomes
these receptors were also detected, highlighting the robustness of the assay and the potential for cross-validation
- Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa
dysregulated membrane trafficking, stability and phototransduction processes that lead to progressive loss
- Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota..
Moreover, independent of glucose control or weight loss, the anti-inflammatory actions of GLP-1RAs require
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
the so-called metabolic surgery whose beneficial effects are beyond dietary restrictions and weight loss
- Comparative study of neuropeptide signaling systems in Hemiptera
Independent secondary losses of the adipokinetic hormone/corazonin-related peptide receptor (ACP) and
- Addex Raises $10 Million In Equity Financing
Company agreed to sell 3,752,202 shares in the form of 625,367 American Depositary Shares (“ADSs”) at a gross
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Helen Su , et al. for their fantastic work on Germline mutations in a G protein identify signaling cross-talk research position GPCR Activation and Signaling Germline mutations in a G protein identify signaling cross-talk
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
damage to healthy cells in the process, leading to side effects that can include pain, nausea, and hair loss
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Heterodimerization when Expressed Heterologously in Saccharomyces cerevisiae The beta 2 adrenergic receptor cross-linked
- Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization
cholesterol-depleted cells (using statins) by fluorescence recovery after photobleaching (FRAP) and fluorescence loss
- GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation
pro-inflammatory properties in colonic macrophages through enhancing NLRP3 inflammasome activation, while the loss








